Gilead Sciences | GILD - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
AbbVie USD 384.69B 19.14B 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
ALKERMES USD 8.17B 562M 2026-07
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 31.46B 4.55B 2026-07
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 82.78B 2.64B 2026-07
Glaxosmithkline GBP 108.55B 736M 2026-07
Incyte USD 28.64B 5.99B 2026-07
J&J USD 602.98B 8.38B 2026-07
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 264.25B 23.66B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03